A probiotic
by general definition is a “Live microbial feed
supplement, which beneficially affects the host by improving
the host’s intestinal microbial balance”.
Probiotics are generally mono or mixed cultures of live
microorganisms which otherwise form the major component
of the gut micro flora (e.g. lactobacilli, bifidobacteria).
How does Probiotics
beneficially affect the host?
Ingestion of probiotics
beneficially affects the host by
Replenishing the depleted gut micro flora, which
may have occurred due to use of antibiotics, illness,
stress, travel or lifestyle changes.
Improving the properties of the indigenous micro
flora.
Probiotic bacteria are generally, though not exclusively,
lactic acid bacteria and include
Lactobacillus species like Lactobacillus acidophilus,
L. casei, L. bulgaricus, L. plantarum, L. salivarius,
L. rhamnosus, L. reuteri.
Bifidobacterium species like Bifidobacterium bifidum,
B. longum, B. infantis. Streptococcus thermophilus,
Saccharomyces boulardii.
What are the different
types of Probiotic bacteria?
Lactobacilli and bifidobacteria :
Lactobacilli and bifidobacteria are Gram - positive
lactic acid producing bacteria that constitute a
major part of the normal intestinal micro flora
in humans and animals. They play an important role
in resistance to colonization against exogenous,
potentially pathogenic microorganisms.
Lactobacilli :
Lactobacilli are Gram - positive, non - spore forming
rods or coccobacilli. They have complex nutritional
requirements, aero tolerant or anaerobic, acidophilic
and are found in habitats rich in carbohydrate containing
substrates such as the human intestinal mucosal
membrane. They predominantly colonize the upper
and lower small intestine.
Lactobacillus sporogenes :
Lactobacillus sporogenes is present predominantly
in the small intestine and helps in synthesis of
B complex vitamins and Vitamin K. It also produces
enzymes required in the digestion of various carbohydrates,
fats, and proteins and also aids in their absorption.
They have the capability of transforming into the
spore form, which gives it stability and the ability
to withstand high temperature, gastric acid and
bile acid. Once consumed by the host, these spores
germinate in the upper small intestine and produce
lactic acid thereby creating an environment, which
will inhibit the growth of potentially pathogenic
organisms. Lactobacillus sporogenes produces biologically
active L (+) lactic acid, which is completely metabolized
leading to glycogen synthesis. The WHO has recommended
use of lactobacillus species that produce L (+)
lactic acid, especially in infant nutritional formula.
Some other strains of lactobacillus like lactobacillus
acidophillus produce L (-) lactic acid, which cannot
be metabolized by the body and so is not preferable
as a nutritional supplement.
Bifidobacteria :
Bifidobacteria are nonmotile, non - spore forming,
Gram - positive rods with varying appearance. Most
strains are strictly anaerobic. They constitute
a major part of the normal intestinal micro flora
in humans throughout life.
Saccharomyces boulardii :
Saccharomyces boulardii belongs to the yeast species.
It is non - pathogenic and non - colonizing. It
is considered transient yeast in the human intestines,
which means that it does not set up residence in
the mucosal membrane of the intestinal tract like
the lactobacillus and bifidobacteria.
Streptococcus thermophilus :
Streptococcus thermophilus are lactic acid producing
aerobic gram-positive cocci. They are mainly found
in the upper and lower small intestine and produce
lactase enzyme, which is helpful in digestion of
lactose, a sugar found in milk.
What is an ideal
Probiotic?
An ideal probiotic would be one which
Contain bacterial species similar to those naturally
present in the human intestinal flora.
2. Contain probiotic species that can inhabit the
whole intestine (small and large intestine).
3. Should be able to protect the small and large
intestine against colonization by potentially pathogenic
organisms.
Should be able to help in proper digestion and
assimilation of nutrients provided through diet throughout
the gastrointestinal tract.
Should be able to synthesize nutrients for the host
(man) like B complex vitamins and Vitamin K, and exert
a beneficial effect on the host.
Should be able to rapidly replenish
the normal gut flora in situations where the normal
gut flora could be altered, as with the use of antibiotics.
Should not be harmful to the host in any situation.
What are the clinical
conditions in which Probiotics can be used?
There are certain clinical
conditions, which are associated with the depletion or
alteration in the normal gut flora. In such situations,
there is a plethora of symptoms, which are predominantly
gastrointestinal in origin.
Intestinal infection (bacteria, virus, protozoa)
Consumption of antibiotics
Lactose intolerance
Surgery involving the bowels
Food fads (increased fat, carbohydrate
and meat intake)
Arising form the changes in the intestinal
milieu through the use of probiotics, a number of health
benefits have been demonstrated, mostly anecdotally and
to some extent in controlled clinical trials .
Increased resistance to infectious diseases, particularly
of the intestines.
Decreased duration of diarrhea (antibiotic associated,
travelers, infective).
Use in lactose intolerance (promotion of intestinal
lactose digestion).
Increased nutritional value
(better digestibility, increased absorption of vitamins
and minerals).
Regulation of gut motility (constipation, irritable
bowel syndrome).
Maintenance of mucosal integrity
of the intestine.
Reduction in serum cholesterol concentration.
Reduction in allergy.
Prevention of colon cancer.
Reduction in carcinogen /co-carcinogen production.
What is a Prebiotic?
Prebiotics are range
of non-digestible dietary supplements, which modify
the balance of the intestinal micro flora, stimulating
the growth and / or activity of beneficial organisms
and suppressing potentially deleterious bacteria.
These supplements include lactulose, lactitol, a variety
of oligosaccharides (especially fructo-oligosaccharides
or FOS), and inulin. In particular, prebiotics promote
the proliferation of bifidobacteria in the colon. Some
of them also help in promoting the proliferation of
lactobacilli in the small intestine to a certain extent.
To be effective, prebiotics should escape digestion
in the upper gut, and reach the large bowel, and be
utilized selectively by a restricted group of microorganisms
that have been clearly identified to a health promoting
properties (e.g. lactobacillus, bifidobacteria).
What are the different
types of Prebiotic bacteria?
Streptococcus faecalis T-110 :
Streptococcus faecalis T-110 are live mutated gram-positive,
aerobic, non-spore forming cocci. They proliferate
actively through the symbiotic action with B. mesentericus
TO-A and C. butyricum TO-A to yield lactic acid
with inhibition of growth of harmful bacteria. This
lactic acid bacteria is found in the region from
the upper to lower part of small intestine.
Clostridium
butyricum TO-A :
Clostridium butyricum TO-A are live mutated gram-positive,
anaerobic, spore forming bacilli. They proliferate
actively through the symbiotic action with streptococcus
faecalis T-110 to yield short chain fatty acids
such as butyric acid and acetic acid with a resultant
decrease in intestinal pH and inhibition of growth
of harmful bacteria. Additionally it acts on the
intestinal tract to improve abnormal bowel movements.
The short chain fatty acids also help in adjustment
of water and electrolyte concentration of the intestinal
tract. They also serve as source of nutrient for
intestinal mucosal cells. It is found predominantly
in the region from the upper small intestine to
the colon.
Bacillius mesentericus TO-A :
Bacillius mesentericus TO-A are live mutated gram-positive,
aerobic, spore forming bacilli. They proliferate
actively through the symbiotic action with streptococcus
faecalis T-110. It is a spore forming bacteria and
produces an amylolytic enzyme (amylase) and protease
to activate proliferation of streptococcus T-110.
It is also responsible for production of a nutrient,
which helps in increasing the count of bifidobacteria.
It is found predominantly in the small intestine.
These three bacteria when given together, colonize
in the respective places in the gastrointestinal
tract and promote each other’s growth and
multiplication in the human gut in a symbiotic manner.
It has been found that these three species of bacteria
grow together in symbiosis twenty times as much,
which would not have been possible in the absence
of symbiosis amongst the three species of bacteria.
Further, in vitro studies have shown that these
bacteria, when cultured together, inhibited the
growth of pathogenic bacteria such as E. coli, Salmonella
species, Shigella species, V. cholera and Staphylococcus
aureus through their symbiotic action.
In vitro studies also demonstrated that there was
a facilitation of division and proliferation of
bifidobacteria when a filtrate of B. mesentericus
TO-A culture solution was added to a culture of
bifidobacteria. Accelerated growth of bifidobacteria
was noted.
The three mutated bacteria have been shown to be
resistant to the action of gastric juice and intestinal
juice including bile. They can therefore pass unaffected
through the upper GI tract (stomach and duodenum)
and colonize in the lower GI tract (upper and small
intestine and colon), when taken orally.
Studies have also shown that these bacteria help
in normalizing the intestinal flora by promoting
the growth of beneficial bacteria and preventing
the growth of harmful bacteria. In cases of intestinal
infection with pathogenic bacteria, intake of these
three mutated bacteria can lower the counts of the
pathogenic bacteria, while simultaneously increasing
the count of beneficial bacteria. This is shown
by a reversal of ratio of predominant aerobic :
anaerobic bacteria to a predominant anaerobic :
aerobic bacterial ratio. Here the aerobic bacteria
signify the potentially pathogenic organisms whereas,
the anaerobic bacteria signify the beneficial resident
bacteria in the intestine.
The increased count of bifidobacteria, generated
in the intestine through the action of the three
mutated bacteria, produces Glutamine
from NH4+ and glutamic acid in the intestine. Glutamine
is the fuel for the intestinal cells and helps in
maintaining the integrity of the intestinal mucosal
barrier. In this manner, the colonization by potentially
pathogenic microorganisms in the intestine is inhibited.
How does these bacteria
act both as Prebiotic and Probiotic?
The
three live bacteria namely, Streptococcus faecalis,
Clostridium butyricum and Bacillus mesentericus, exert
their prebiotic action in the gut by raising the counts
of bifidobacteria and lactobacillus. These three live
bacteria also have the property of producing lactic
acid, butyric acid and acetic acid which create an acidic
environment in the intestine, which in turn is detrimental
to the colonization and growth of intestinal pathogenic
bacteria like E. coli, Salmonella, Shigella, Clostridium,
Streptococcus and Staphylococcus.
In this way these three mutated live bacteria, which
are non-pathogenic and which help each other to multiply
and proliferate by a process of symbiosis, act as both
a PREBIOTIC (by its property of facilitating
proliferation of normal gut flora bacteria like bifidobacteria
and lactobacillus) and a PROBIOTIC
(by its property of creating and acidic environment
in the intestine and inhibiting the proliferation of
potentially pathogenic organisms, thereby beneficially
affecting the host).
The three bacteria continue to proliferate in the GI
tract of man by a process of SYMBIOSIS,
which is defined as a biological association of two
or more species to their mutual benefit.